This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany

Henriette Rozema
Head of Global Manufacturing Science and Technology at Galapagos
Speaker

Profile

Henriette Rozema is the Global Head of Manufacturing Science and Technology at Galapagos, where she leads a team dedicated to optimizing manufacturing processes, deploying innovations, and driving successful technology transfers across the company’s decentralized cell therapy manufacturing network. With over 15 years of experience at Johnson & Johnson in vaccine process development and technology transfer, and several years at Galapagos, she combines deep technical expertise with a passion for translating scientific progress into real-world impact for patients

Agenda Sessions

  • How to Show Comparability for Fresh (Non-Cryopreserved) Autologous Ex-Vivo Gene Therapy Products, Manufactured across a Network of Decentralised Manufacturing Sites

    10:10